Table 4. Predictive ability of A-FABP and chemerin for significant ischemia.

	Overall OR (95% CI)	p	Men	p	Women	p
Model 0
A-FABP	2.0 (1.0–3.9)	0.05	2.9 (0.8–9.8)	0.09	2.1 (0.8–5.5)	0.14
Chemerin	3.2 (0.6–17.1)	0.17	1.8 (0.2–16.6)	0.58	4.2 (0.4–40.8)	0.22
Model 1
A-FABP	2.3 (1.1–4.8)	0.03	2.7 (0.7–9.6)	0.13	4.1 (1.3–13.7)	0.02
Chemerin	3.7 (0.7–20.2)	0.13	1.4 (0.2–14.1)	0.73	6.6 (0.6–78.7)	0.14
Model 2
A-FABP	2.3 (1.1–4.8)	0.03	2.4 (0.7–8.3)	0.18	4.9 (1.2–18.7)	0.02
Chemerin	5.1 (1.1–24.7)	0.04	1.7 (0.2–16.1)	0.63	7.5 (0.6–102.6)	0.13
Model 3
A-FABP	2.3 (1.1–4.8)	0.04	2.0 (0.6–7.4)	0.30	5.2 (1.3–20.5)	0.02
Chemerin	4.4 (0.8–24.4)	0.09	2.3 (0.2–24.4)	0.48	5.8 (0.6–60.1)	0.14

Model 0: no adjustment.

Model 1: adjusted for age.

Model 2: adjusted for age, systolic blood pressure.

Model 3: adjusted for age, systolic blood pressure, history of coronary artery disease.

A-FABP, adipocyte fatty acid-binding protein.